ADXN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Addex Therapeutics Ltd (ADXN) is not a strong buy at the moment for a beginner investor with a long-term focus. The technical indicators show a bearish trend, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. The financial performance reflects declining revenue and negative net income, which does not support a compelling growth story. Given the lack of strong positive signals, holding off on buying this stock is advisable.
ADXN is showing bearish technical indicators. The MACD is negative and expanding downward, the RSI is neutral at 39.289, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 7.02), but there is no clear signal for a reversal.
NULL identified. No recent news or significant insider or hedge fund activity.
and negative net income, despite a slight improvement in net loss. The broader market (S&P
is also down, which may indicate a challenging macroeconomic environment.
In Q3 2025, revenue dropped by 7.97% YoY to 62,014.92. Net income improved slightly but remains negative at -1,972,013.2 (+11.60% YoY). EPS and gross margin showed no change YoY, with EPS at -0.02 and gross margin at 100.
No data on analyst ratings or price target changes was provided.
